Desperation drives patients

This release is also available in French, Spanish, German, and Italian.

Oncologists were urged to be more responsive to cancer patients who want to try alternative medicines. Speaking today (18 October 2002) at the European Society for Medical Oncology Congress in Nice, France, Professor Edzard Ernst from the Peninsula Medical School, Universities of Exeter & Plymouth, UK, said that a lack of openness to other forms of treatment is what drives people to alternative therapies. If they feel they cannot discuss it with their physician it can endanger their lives.

"Be open," said Professor Ernst. "People with cancer are desperate for treatment and will try anything. You would probably do the same!", he told delegates.

Many forms of complementary and alternative medicines are promoted as a prevention of cancer. There is little risk associated with garlic, green tea, phytoestrogens, and panax ginseng, although there is only weak evidence that they are effective.

More alarmingly, there is an increasing number of complementary and alternative therapies that claim to cure cancer, often supported by quasi-scientific data. Essiac, Di Bella therapy, Hoxley formula, mistletoe, and shark cartilage are a few examples of substances that can be dangerous to the patient.

Professor Ernst, who is director of complementary medicine at the medical school, carries out research to acquire much needed data on the efficacy and safety of alternative therapies. "Whether we love or hate them, we must answer the basic questions about complementary or alternative remedies," he said. Little is known about their interaction with conventional medicine and it can be tempting f

Contact: Gracemarie Bricalli
European Society for Medical Oncology

Page: 1 2

Related medicine news :

1. Rutgers-developed biomaterial drives a technology transfer story toward success
2. Hormonal treatment improves survival in high-risk prostate cancer patients
3. Study finds that coordinating care of chronically ill patients does not increase liability
4. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
5. Optical technique identifies vulnerable plaques in cardiac patients
6. NHS target driven culture is failing patients
7. Cardiac deaths peak in sleep hours for patients with sleep apnea
8. Chronic fatigue patients show lower response to placebos
9. Depression linked to insomnia in HIV patients
10. Disfigured patients may be forced to forego surgery
11. Massive weight loss patients create mass appeal for body contouring procedures

Post Your Comments:

(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
Cached News: